Good morning, ladies and gentlemen. My name is Robert Epstein, and I am the chair of the Board of Veracyte. I will be serving as chair of the meeting as we proceed, and it is a pleasure to welcome you to our 2026 annual meeting of stockholders and to introduce Marc Stapley, CEO of Veracyte and a member of our Board of Directors, Rebecca Chambers, CFO of Veracyte, and Annie McGuire, general counsel and head of market access, who will serve as Secretary of the meeting. The meeting is now called to order. First, I'd like to introduce the other directors of Veracyte who are present on the line today. Eliav Barr, Muna Bhanji, Karin Eastham, Jens Holstein, Evan Jones, Tom Miller, and Brent Shafer. I would also like to introduce representatives of Ernst & Young LLP, our auditing firm, who are present on the line today, Graham Reed and Jamie Steshe. I would also like to introduce Jim Krenn and Tyler Miller from Morrison & Foerster LLP, our outside legal counsel. Will the Secretary of the meeting, Annie McGuire, report on the calling and notice of this annual meeting? Thank you, Rob. Stockholders of record as of the close of business on April 15th, 2026, the record date, are entitled to receive notice of and to vote at this meeting. I present to this meeting an affidavit of Broadridge Financial Solutions to evidence the mailing of this notice sent by U.S. Mail on or about April 22nd, 2026. The affidavit of mailing of notice will be attached to the minutes of this meeting. In addition, Alex Tull, our Director of SEC Reporting and SOX, has been appointed as the Inspector of Election and his oath of office will be filed with the minutes. He has a certified list of stockholders entitled to vote at this meeting. This list will be available for inspection during this meeting by any stockholder online and will be filed with the records of the company. I declare that the meeting has been duly called and that notice has been duly given. Will the Inspector of Election please present his report? The bylaws of the company provide that the presence, either in person or by proxy, of a majority of shares issued and outstanding and entitled to vote at the meeting shall constitute a quorum. Mr. Chairman, there are present, either in person or by proxy, at least 72,674,448 shares, or 91% of the total shares of common stock of Veracyte entitled to vote. I declare that a quorum is present and that this meeting is ready to transact business. The polls are now open. Stockholders may vote online at www.virtualshareholdermeeting.com/vcyt2026. If you have already returned a proxy or voted by phone or through the Internet, you need not vote again online at this meeting unless you wish to change your vote. Your vote has already been included in the proxy count. If any stockholder has not voted by proxy prior to the meeting and now wishes to vote, or if any stockholder wishes to change his or her vote from that previously recorded, please vote or change your vote online on the website you have logged into to listen to the annual meeting. After you have completed or changed your vote online and we have completed consideration of the items on the agenda, we will tabulate your proxies and ballots. The first item of business is the election of nine directors for a one-year term expiring at the 2027 annual meeting. Based on the recommendation of the Nominating and Corporate Governance Committee, the board of directors has nominated the following persons to serve as such directors: Eliav Barr, Muna Bhanji, Karin Eastham, Robert Epstein, Jens Holstein, Evan Jones, Tom Miller, Brent Shafer, and Marc Stapley. The second item of business is the proposal to ratify the audit committee's appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. The third item of business is the proposal to approve, on a non-binding advisory basis, the compensation of the company's named executive officers as disclosed in the proxy statement. As an advisory vote, this item is non-binding. The board of directors and Compensation Committee value the opinions expressed by stockholders in their vote for this proposal and will consider the outcome of the vote when making future compensation decisions of our named executive officers. On behalf of the board of directors and for the reasons set forth in the proxy statement, I will now present the proposed resolution. Resolved that our stockholders hereby approve, on a non-binding advisory basis, the compensation of the company's named executive officers as disclosed in the proxy statement pursuant to Item 402 of Reg S-K, including compensation tables and narrative discussion and other related disclosures. The fourth item of business is the proposal to approve an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan as disclosed in the proxy statement, hereinafter referred to as the Plan Amendment. If approved by our stockholders, the Plan Amendment will, among other items, increase the aggregate number of shares of common stock authorized for issuance under our 2023 Equity Incentive Plan by 3.5 million shares. If you have not already voted, please do so online right now. It is now approximately 10:10 A.M. on June 10th, 2026, and I now declare the polls for each matter voted upon at this meeting closed. Will Alex Tull now please tally the proxies and ballots and prepare the report of the vote? Based upon the final tabulation of the vote, those persons nominated as directors have been elected. The appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2026, has been ratified. The stockholders have approved, on a non-binding advisory basis, the compensation of the named executive officers. The stockholders have approved the Plan Amendment. The final report of the Inspector of Elections will be included as part of the record of this meeting. The final voting results will be included in a filing with the Securities and Exchange Commission. This concludes the formal business portion of the 2026 annual meeting of the stockholders of Veracyte, Inc. We appreciate your interest and support, and we thank you very much for joining us this morning. At this point, I'd like to entertain any questions that you may have. To ask a question, please input the question in writing where indicated on the webcast portal for this meeting. Only stockholders will be permitted to present questions, and you must have your 16-digit control number to do so. Before doing so, I would like to remind everyone that during the course of this annual meeting of stockholders, we may make projections or other forward-looking statements regarding future events or the future financial performance of the company. I wish to caution you that these statements are only predictions and that actual events or results may differ materially. We are under no obligation to update or revise any forward-looking statements. I refer you to documents the company files from time to time with the Securities and Exchange Commission, specifically the company's annual report on Form 10-K for the year ended December 31, 2025, and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, which could be found on our website, www.veracyte.com. These reports contain important factors and a discussion of risks that could cause the actual results to differ materially from those contained in our projections or forward-looking statements. We will now review any questions submitted. There appear to be no questions. Thank you very much. This concludes today's meeting. You may now disconnect.